Dec 29 (Reuters) - Ultragenyx Pharmaceutical (RARE.O), opens new tab said on Monday that late-stage studies showed its drug for a type of genetic bone disease failed to reduce the number of fractures ...
An international clinical trial involving Aston University researchers has challenged long held assumptions about how brittle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results